Name | Bisandrographolide A |
---|---|
Synonyms |
2(5H)-Furanone, 5-[2-[(1R,4aS,5R,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]-1-(2,5-dihydro-2-oxo-3-furanyl)ethyl]-3-[(E)-2-[(1R,4aS,5R,6R,8aR)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethenyl]-
5-{2-[(1R,4aS,5R,6R,8aS)-6-Hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]-1-(2-oxo-2,5-dihydro-3-furanyl)ethyl}-3-{(E)-2-[(1R,4aS,5R,6R,8aR)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]vinyl}-2(5H)-furanone |
Description | Bisandrographolide A (BAA) activates TRPV4 channel with an EC50 of 790-950 nM. Bisandrographolide A can bind to CD81 and suppress its function. Bisandrographolide A is an anti-inflammatory, immunostimulant, and antihypertensive compound[1][2]. |
---|---|
Related Catalog | |
Target |
TRPV4 channel[1]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 832.6±65.0 °C at 760 mmHg |
Molecular Formula | C40H56O8 |
Molecular Weight | 664.868 |
Flash Point | 252.3±27.8 °C |
Exact Mass | 664.397522 |
PSA | 133.52000 |
LogP | 3.82 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.596 |